We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

H2O:BVBS.P.E.E.H. Hidroelectrica S.A. Analysis

Data as of 2026-06-22 - not real-time

$56.69

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock trades just below its short‑term moving averages, with the 20‑day and 50‑day SMAs perched slightly above the current price while the 200‑day SMA remains well beneath, suggesting a neutral to mildly bearish technical stance. RSI hovers around the neutral 50 mark and the MACD line sits beneath its signal, reinforcing modest downside pressure, yet volume has stayed stable, providing liquidity support. Fundamentally, the price‑to‑earnings ratio is a shade under the industry norm, but a high debt‑to‑equity ratio and negative free cash flow raise concerns about financial flexibility, and the discounted cash‑flow estimate sits markedly below the market price, implying the stock may be overvalued. Dividend yield exceeds three percent with a payout below sixty percent, which, combined with the regulated nature of the water utility business, points to sustainable income despite the valuation headwinds. The recent extreme greed reading on the fear‑greed index and a volatility level that is high for a utility further suggest that market sentiment may be overly optimistic at this juncture.
Looking ahead, the blend of modest growth prospects from non‑tariff services and a solid dividend makes the company attractive for long‑term investors, but the current pricing, leverage, and cash‑flow profile warrant caution. A neutral to slightly bearish short‑term outlook is appropriate, while a medium‑term hold stance reflects the balance between valuation pressure and dividend appeal. Over the long horizon, the regulated cash‑flow base and dividend sustainability could justify a buy position if the market corrects toward intrinsic value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD crossover
  • Stable trading volume

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Slightly below industry PE but high leverage
  • Sustainable dividend yield
  • Neutral RSI indicating balanced momentum

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Regulated cash‑flow base and dividend sustainability
  • Potential upside if market price aligns with DCF valuation
  • Blend of modest growth from non‑tariff services

Key Metrics & Analysis

Financial Health

Revenue Growth9.40%
Profit Margin12.87%
P/E Ratio19.4
ROE6.50%
ROA2.35%
Debt/Equity102.18
P/B Ratio1.3
Op. Cash Flow$245.3M
Free Cash Flow$-261451008
Industry P/E20.6

Technical Analysis

TrendNeutral
RSI47.3
Support$56.00
Resistance$59.13
MA 20$57.20
MA 50$57.71
MA 200$52.74
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair Value$39.27
Target Price$63.71
Upside/Downside12.39%
GradeOvervalued
TypeBlend
Dividend Yield3.11%

Risk Assessment

Beta-0.19
Volatility21.33%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.